10x Genomics
TXG
#4457
Rank
โ‚น202.02 B
Marketcap
โ‚น1,596
Share price
-2.09%
Change (1 day)
23.78%
Change (1 year)

Revenue for 10x Genomics (TXG)

Revenue in 2025 (TTM): โ‚น55.45 Billion

According to 10x Genomics 's latest financial reports the company's current revenue (TTM ) is โ‚น57.65 Billion. In 2024 the company made a revenue of โ‚น52.39 Billion an increase over the revenue in the year 2023 that were of โ‚น51.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for 10x Genomics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น55.45 B5.83%
2024 โ‚น52.39 B1.73%
2023 โ‚น51.50 B20.54%
2022 โ‚น42.73 B17.05%
2021 โ‚น36.50 B67.04%
2020 โ‚น21.85 B24.64%
2019 โ‚น17.53 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚น57.69 B 0.07% Jersey
Novavax
NVAX
โ‚น92.02 B 59.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น12.93 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น1.96 B-96.60%๐Ÿ‡ฌ๐Ÿ‡ง UK